Improving Nutrition and Health Outcomes in Intibuca, Honduras (MANI I)
MANI I
1 other identifier
interventional
300
0 countries
N/A
Brief Summary
The purpose of this research study is to assess what impact an integrated educational and feeding intervention delivered to infants and children has on growth (weight and height), development (cognitive and gross motor), nutrition (dietary behaviors, food insecurity, and micronutrient status - folate, iron, zinc, vitamin A, vitamin D), and morbidity (respiratory and diarrheal) outcomes. A randomized community trial was used to implement a nutrition intervention program consisting of monthly education sessions, a lipid-based nutrition supplement, and food vouchers for local staples.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2009
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2010
CompletedFirst Submitted
Initial submission to the registry
March 5, 2011
CompletedFirst Posted
Study publicly available on registry
March 11, 2011
CompletedAugust 2, 2011
July 1, 2011
1.1 years
March 5, 2011
July 31, 2011
Conditions
Outcome Measures
Primary Outcomes (5)
Change from baseline in height at 12 months
Participating children were measured by trained staff every month during the 12 month intervention.
Baseline to month 12
Change from baseline in hemoglobin status at 12 months
Hemoglobin status was measured from blood samples taken by finger pricks at baseline, month 6, and month 12 of the intervention.
Baseline to month 12
Change from baseline in serum transferrin status at 12 months
Serum transferritin was measured from blood samples taken by finger pricks at baseline, month 6, and month 12 of the intervention.
Baseline to month 12
Change from baseline in C-Reactive Protein levels at 12 months
C-Reactive Protein was measured from dried blood spots collected at baseline, month 6, and month 12 of the intervention.
Baseline to month 12
Change from baseline in weight at 12 months
Participating children were weighed by trained staff every month during the 12 month intervention.
Baseline to month 12
Secondary Outcomes (7)
Change from baseline in zinc levels at 12 months
Baseline to month 12
Change from baseline in food insecurity status at 12 months
Baseline to month 12
Change from baseline in dietary intake based on 24-Hour Food Recall at 12 months
Baseline to month 12
Change from baseline in various health outcomes at 12 months
Baseline to month 12
Change from baseline in acceptability of nutrition supplement at 12 months
Baseline to month 12
- +2 more secondary outcomes
Study Arms (2)
Nutrition intervention
EXPERIMENTALReceives a month's supply of the nutrition supplement, Plumpy'doz®, in addition to food voucher for each month. Participants were also allowed to attend monthly educational sessions.
Control
NO INTERVENTIONReceives food vouchers each month.
Interventions
After gradual introduction of the lipid-based nutritional supplement, daily dose per child is as follows: 3 teaspoons 3 x day for children younger than 12 months 4.5 teaspoons 3 x day for children older than 12 months
Eligibility Criteria
You may not qualify if:
- Mothers have understood and signed consent forms to enable their children to participate in the study. They were willing to have their child participate in one or more blood draws, bi-monthly sessions: 1) nutrition classes and food voucher and lipid-based nutritional supplement and 2) height/weight monitoring, dietary intake questionnaire, and health outcome information. As well as the additional data assessments necessary to be considered active participants in the study.
- Children with congenital anomalies, mental retardation, severe physical handicap, under-nutrition caused by medical conditions that contribute to under-nutrition such as heart disease, kidney failure, face and throat problems that interfere with swallowing, medical problems interfering with the absorption of food, chronic diseases such as tuberculosis, etc.
- Children with a known allergy to peanuts and eggs will also be excluded from the study, 30% of children with known allergies to nuts also have an allergy to eggs.
- Plans to move or change their place of residence outside of the study region in the next 2 months would make them ineligible.
- Mothers who are younger than 16 years of age will be excluded from the study. Women younger than 16 might not understand the consent process and the importance of following the guidelines established in the research, therefore we chose not to include this group as "eligible" participants.
- Children who are \<= -2 standard deviations below the norm for z score for weight for age. These children are severely malnourished and need to be carefully followed under the supervision of a qualified health care provider.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jeff Heck, MD
Shoulder to Shoulder
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
March 5, 2011
First Posted
March 11, 2011
Study Start
March 1, 2009
Primary Completion
April 1, 2010
Study Completion
April 1, 2010
Last Updated
August 2, 2011
Record last verified: 2011-07